Volume 15 - Issue 11 - November 2018
Case Report
VASCULAR DISEASE MANAGEMENT 2018;15(11):E133-E135
Hannes Melnyk, MD1; Hubert Gufler, MD2; Dietrich Stoevesand, MD2; Jochen Schröder, MD1; Konstantin Heinroth, MD1
1Department of Medicine III and 2Department of Diagnostic Radiology, University Hospital Halle (Saale), Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany
Hannes Melnyk, MD, and colleagues discusses the case of a young patient without known malformations who presented with extracardiac shunt between the left pulmonary artery and the left upper pulmonary vein.
Case Report
VASCULAR DISEASE MANAGEMENT 2018;15(11):E130-E132
Hiranya A. Rajasinghe, MD1; Larry E. Miller, PhD2; Santiago H. Chahwan, MD1; Alvaro J. Zamora MD
1The Vascular Group of Naples, Naples, Florida
2Miller Scientific Consulting, Asheville, North Carolina
Patients treated with the lower-profile AFX Strata endograft have an increased risk of type III endoleak which may be treated with relining, according to a case report.
Editor's Corner
VASCULAR DISEASE MANAGEMENT 2018;15(11):E126
Craig Walker, MD
Craig Walker, MD, opens the November issue of VDM by discussing the treatment of common femoral artery (CFA) disease in patients who are not surgical candidates for CFA endarterectomy.
Commentary
VASCULAR DISEASE MANAGEMENT 2018;15(11):E127-E129
Sofia D.C. Vianna, MD; Omosalewa Adenikinju, MD; Brandon P. Olivieri, MD; Timothy E. Yates, MD; Robert E. Beasley, MD
Department of Vascular and Interventional Radiology at Mount Sinai Medical Center, Miami Beach, Florida
Available data suggest that common femoral artery atherosclerosis with or without patch angioplasty has a high 5-year patency rate and a relatively low rate of postoperative complications.
Back to Top